The management of epithelial ovarian cancer: neoadjuvant chemotherapy and interval surgery

Abstract

Ovarian cancer is the fourth most common cause of death from cancer in women and remains a significant problem. Treatment continues to be difficult as most women have advanced stage cancers at presentation. Some progress in terms of management and survival has been made in the last 20 years, but the mortality rate remains high. Improving outcomes in terms of mortality and quality of life will rely on a better understanding of the aetiology, effective population screening and increased management options.